Navigation Links
Breast Cancer Survivors Fail To Show Interest In Follow Up Mammogram

Women diagnosed with breast cancer no doubt receive best possible treatment for the deadly disease following the first one-year of treatment. It is recommended that such women receive a follow-up mammogram, to assess the treatment outcome. // This is to a large extent ignored by most early-stage breast cancer survivors, according to a latest study published in the Journal of Clinical Oncology.

Such mammograms can go a long way in the identification of any adverse effects associated with the cancer treatment and the early detection of secondary cancer, if any. Further, it can ensure that the breast cancer remains in remission. Currently, 815 breast cancer survivors exist for every 100,000 women in the United States.

Researchers from the Lombardi Comprehensive Cancer Center analyzed the primary treatment given to women with either stage I or stage II breast cancer. The study participants were required to provide extensive information about the health care provided following one year of treatment. Nearly 558 women were recruited for the study, out of which 391 were able to provide the requested information.

A close examination of the data revealed that the breast cancer survivors on an average utilized health care services approximately 30 times on an average compared to the general public. Visits to the cancer clinic were found to account for a major proportion of the treatment cost.

Furthermore, variations in the treatment strategies and costs, based on diverse geographic locations were documented. The presence of other concomitant diseases, the physical and mental health status (depression) of the cancer patient, was found to play a major role in determining the treatment modality. These factors were associated with increased visits and treatment costs.

Despite the fact that all these women should have had a mammography following the first one-year of treatment, only 62% of those studied w ere found to have had a mammogram. Comparatively, women treated by lumpectomy were more likely to have a mammogram than those with a history of mastectomy. The same effect was observed in white and nonwhite women. This could be attributed to a better educational status and increased health awareness among white women.

The results of the present study have several valuable implications. First, it highlights the existing lacunae in the diagnosis and treatment of breast cancer, amongst the so-called developed countries. Secondly, it necessitates an improvement in the use of mammography for monitoring breast cancer treatment. Finally, it must be ensured that all breast cancer survivors should be encouraged to actively participate in their treatment process that would result in a superior outcome.


'"/>




Related medicine news :

1. Consensus on "Combination Therapy" for Breast Cancer
2. Breast cancer treatment to be determined by gene test
3. Breast Feeding prevents obesity later on in life
4. Breast milk is essential
5. Breast Cancer Surgery Causes Psychological problems
6. Breast cancer evidence
7. Letrozole Beats Tamoxifen in Breast Cancer Therapy
8. Breast screening among diabetic women
9. Breast feeding can alter hormones
10. Diet, Sunlight connected to Breast Cancer Risk
11. Additional Radiotheraphy for Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/12/2017)... ... 12, 2017 , ... First Healthcare Compliance (FHC), an industry ... a range of technology and learning solutions at the 68th Annual American Healthcare ... be held October 14–18, 2017 at the Mandalay Bay Resort in Las Vegas, ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has ... today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every formula ... the highest standard. , These products are also: Gluten Free, Non-GMO, Vegan, ...
(Date:10/12/2017)... ... ... Asante, a nationally recognized health system in southern Oregon, ... health joint venture through an agreement, effective October 1, 2017, to create AccentCare ... company with Asante, delivering clinically integrated care, for the past eight years. This ...
(Date:10/12/2017)... ... ... HMP , a leader in healthcare events and education, today announced that ... for ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie & Ozzie Awards ... recognizes editorial and design excellence across a range of sectors. This year’s program included ...
(Date:10/12/2017)... ... October 12, 2017 , ... Women-owned ... Michigan’s 2017 Best and Brightest in Wellness® by Best and Brightest. OnSite Wellness ... on Friday, Oct. 20 from 7:30 a.m. to 2 p.m. at the Henry ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... YORK , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a ... today announced that its MyDario product is expected to appear on The ... when The Dr. Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. Oz ... The ...
(Date:9/23/2017)... 2017 Janssen Biotech, Inc. (Janssen) announced today ... the U.S. Food and Drug Administration (FDA) for the ... the treatment of moderately to severely active rheumatoid arthritis ... are needed to further evaluate the safety of sirukumab ... "We are ...
(Date:9/19/2017)... -- HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy ... team developments today:   ... ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D ...
Breaking Medicine Technology: